10-Q: Longduoduo Q3 Loss Widens Amid Revenue Decline

Sentiment:

Quarterly Report


Longduoduo Company Limited reported a significant increase in net loss to $111,182 for the quarter ended September 30, 2025, as total revenues decreased by 14% year-over-year.

Capital raiseThe company anticipates raising additional funds from a public offering and/or debt financing to fund future growth and capital expenditures.The majority shareholder, Zhang Liang, is expected to provide support in the future, if needed.
Worse than expectedNet loss increased by 87% year-over-year.Total revenues decreased by 14% year-over-year.Service revenue declined drastically, leading to a negative gross margin for that segment.Loss from operations increased by 36%.Cash and cash equivalents decreased during the quarter.The company disclosed material weaknesses in its internal controls.

Summary

  • Net loss increased by 87% to $111,182 for the three months ended September 30, 2025, compared to $59,504 in the prior year.
  • Total revenues decreased by 14% to $658,764, down from $769,072 in the same period last year.
  • Service revenue plummeted from $46,595 to $5,606, resulting in a gross loss of $1,104 from service revenue.
  • Commission revenue also saw a decline, from $722,477 to $653,158.
  • Loss from operations increased by 36% to $84,414.
  • Cash and cash equivalents stood at $1,247,296 as of September 30, 2025, a decrease from $1,642,721 at June 30, 2025.
  • The company reported material weaknesses in its disclosure controls and procedures, including a small accounting staff, lack of U.S. GAAP expertise, and insufficient documentation.

Sentiment

Score: 2

Explanation: The company reported a significant increase in net loss and a substantial decline in revenue, particularly in its service segment. Material weaknesses in internal controls and high customer concentration are major concerns. While cash used in operations improved, the overall financial health and going concern warning indicate a very negative outlook.

Positives

  • Net cash used in operating activities improved to $374,184 from $534,998 in the prior year.
  • Net cash used in investing activities improved to $29,948 from $56,431 in the prior year.
  • Other income, net, significantly increased to $40,326 from $2,752.
  • Operating expenses decreased by 8% ($62,404) due to tactical reductions in administrative services and professional fees.

Negatives

  • Net loss increased by 87% to $111,182 for the quarter ended September 30, 2025.
  • Total revenues decreased by 14% year-over-year to $658,764.
  • Service revenue experienced a sharp decline from $46,595 to $5,606, leading to a negative gross margin of -20% for service revenue.
  • Loss from operations increased by 36% to $84,414.
  • Cash and cash equivalents decreased by $395,425 during the quarter to $1,247,296.
  • Accumulated deficit increased to $6,260,151.
  • Provision for income taxes significantly increased to $67,094 from $180.
  • High customer concentration with one customer accounting for 99.1% of revenue.
  • Significant cash ($848,390) held in Chinese banks in excess of insured amounts.

Risks

  • The economic environment has led to a decrease in customer health expenditures, impacting revenue.
  • Unfavorable government policies, increased SEC scrutiny of China-based operations, capital controls, or tariffs may adversely affect business, operating results, ability to raise capital, and share price.
  • There is no assurance of generating sufficient cash flows from operations or obtaining additional financing to remain a going concern.
  • High customer concentration (one customer accounted for 99.1% of revenue) and reliance on a few major suppliers pose significant risks.
  • Significant cash holdings in Chinese banks ($848,390) are in excess of insured amounts, posing a risk in case of bank failure.
  • Material weaknesses in disclosure controls and procedures were identified, including lack of segregation of duties, insufficient U.S. GAAP expertise among financial staff, CFO unfamiliarity with U.S. public company reporting, and inadequate documentation.
  • There is uncertainty in utilizing PRC net operating loss carry forwards of approximately $535,445, leading to a 100% valuation allowance.

Future Outlook

Management believes that government policies recently introduced to promote economic recovery may take some time to truly improve the situation. The company is implementing plans to improve its operations by adjusting operational policies and will continue to invest heavily in advertising and promotion expenses in the near future to establish and expand its brand, products, and services. Future liquidity requirements are expected to be funded by cash generated from operations and raising additional funds from a public offering and/or debt financing.

Management Comments

  • "Important factor influencing revenue in the recent quarter is the impact of the economic environment, which has led to a decrease in customer health expenditures."
  • "Management believes that the government has recently introduced policies to promote economic recovery, but it may take some time for the situation to truly improve."
  • "Meanwhile, as we wait for the economy to revive, the Company is implementing plans to improve its operations by adjusting its operational policies."
  • "The Company will continue to invest heavily in advertising and promotion expenses in the near future as it continues to establish and expand its brand and products and services."
  • "We anticipate that our future liquidity requirements will arise from the need to fund our growth, pay current obligations and future capital expenditures."
  • "The primary sources of funding for such requirements are expected to be cash generated from operations and raising additional funds from a public offering and/or debt financing."
  • "We expect Zhang Liang, our majority shareholder, to continue to provide support in the future, if needed."
  • "However, we can provide no assurances that we will be able to generate sufficient cash flows from operations and/or obtain additional financing on terms satisfactory to us, if at all, to remain a going concern."

Industry Context

The company operates in the preventive healthcare solutions sector in China, a market potentially influenced by government policies aimed at economic recovery. The decline in customer health expenditures suggests a challenging consumer spending environment, which could be a broader trend affecting discretionary healthcare services. The company's reliance on a single major customer for nearly all its revenue highlights a significant concentration risk, which is generally not ideal in any industry. The increased SEC scrutiny of China-based operations adds a layer of regulatory uncertainty specific to companies with cross-border ties.

Comparison to Industry Standards

  • The significant decline in service revenue and overall revenue, coupled with a widening net loss, suggests underperformance compared to a healthy growth-oriented industry standard.
  • A gross margin of -20% for service revenue is highly unusual and indicates severe operational inefficiencies or pricing issues, far below typical industry profitability benchmarks.
  • The high customer concentration (99.1% from one customer) is a critical vulnerability, far exceeding diversified revenue models common in stable businesses.
  • The disclosed material weaknesses in internal controls, including lack of U.S. GAAP expertise and segregation of duties, fall significantly short of best practices for publicly traded companies, especially those subject to SEC reporting requirements.
  • The company's explicit statement about no assurance of remaining a 'going concern' indicates a severe financial health concern, which is a red flag compared to financially stable industry peers.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control Weaknesses IdentifiedMaterial weaknesses in disclosure controls and procedures were identified, including a small number of employees preventing segregation of duties, internal financial staff lacking U.S. GAAP expertise, the CFO not being familiar with U.S. public company accounting/reporting requirements, and insufficient documentation of financial processes, risk assessment, and internal controls.2025-09-30These weaknesses indicate a high risk of financial misstatement and non-compliance with regulatory requirements, potentially impacting investor confidence and operational efficiency.

Related Party Transactions

  • Due from related parties: Zhou Hongxiao (CEO) $301.
  • Due to related parties: Zhang Liang (majority shareholder) $409, Xu Huibo (President and Chairman) $1,054.

Stakeholder Impact

  • Shareholders: Negative impact due to increased net loss, declining revenue, and a warning about the company's ability to remain a going concern. The identified material weaknesses in internal controls also pose a risk to financial reporting reliability.
  • Customers: Potential impact from 'adjusting operational policies' and the company's financial struggles, though the filing does not specify direct customer impact.
  • Employees: The small number of employees responsible for accounting functions suggests potential overwork or lack of specialized roles, and the mention of reducing administrative services could imply job security concerns.
  • Creditors: Increased risk due to the company's liquidity concerns and the explicit statement about no assurance of remaining a going concern.

Next Steps

  • Implement plans to improve operations by adjusting operational policies.
  • Continue to invest heavily in advertising and promotion expenses to establish and expand brand, products, and services.
  • Seek additional funds from a public offering and/or debt financing.
  • Address material weaknesses in disclosure controls and procedures, including improving segregation of duties, enhancing U.S. GAAP expertise, and documenting financial processes.

Key Dates

DateDescription
2020-06-18Inner Mongolia Qingguo Health Consulting Company Limited (Qingguo) registered.
2020-08-20Longduoduo Health Technology Company Limited registered in Inner Mongolia, China.
2020-09-08Longduoduo Health Technology acquired 90% ownership of Qingguo.
2021-03-18Inner Mongolia Rongbin Health Consulting Company Limited (Rongbin) registered.
2021-04-09Inner Mongolia Chengheng Health Consulting Company Limited (Chengheng) registered.
2021-07-05Inner Mongolia Tianju Health Consulting Company Limited (Tianju) registered.
2021-07-26Longduoduo Company Limited (Hong Kong) (Longduoduo HK) established.
2021-08-16Longduoduo HK acquired 100% ownership of Longduoduo Health Technology.
2021-10-25Longduoduo Company Limited incorporated in Nevada.
2021-10-26Longduoduo issued 30,000,000 shares to original shareholders of Longduoduo HK in exchange for 100% of Longduoduo HK.
2023-06-01Company began engaging in agent sales of preventive healthcare solutions and earning commissions revenue.
2023-09-21Company filed for a 1-for-10 reverse stock split.
2023-09-261-for-10 reverse stock split became effective.
2024-03-14Beijing Yihua Health Consulting Co., Limited (Yihua) established.
2024-03-18LDD Technology Limited (LDD) established.
2024-04-01Tianju leased office space under an operating lease agreement.
2024-04-09LDDJK Hong Kong Limited (LDDJK) established.
2024-07-23Beijing Julong Health Consulting Co., Limited (Julong) established.
2024-08-14Qingguo leased office space under an operating lease agreement.
2024-09-10Start date of Qingguo's lease payments for office space.
2024-11-20Chengheng leased office space under an operating lease agreement.
2025-01-07Julong acquired 100% ownership of Yihua.
2025-02-19Longduoduo issued 10,020 shares of common stock to original shareholders of LDD in exchange for 100% of LDD.
2025-03-11Longduoduo Health Technology leased office space under an operating lease agreement.
2025-04-02Julong acquired 100% of Longduoduo Health Technology from Longduoduo HK.
2025-07-20Rongbin leased office space under an operating lease agreement.
2025-08-08Chengheng leased office space under an operating lease agreement.
2025-08-20Rongbin leased office space under an operating lease agreement.
2025-09-01Start date of Rongbin's lease payments for office space.
2025-09-19Qingguo signed a non-cancellable operating agreement to lease office space.
2025-09-30End of the quarterly period covered by the report.
2025-11-12Date of filing of the report and certification by CEO and CFO.

Recommendation

strong sell

The company exhibits severe financial distress with an 87% increase in net loss and a 14% revenue decline, including a negative gross margin for its core service revenue. Significant liquidity concerns are explicitly stated, with no assurance of remaining a going concern without external financing. Furthermore, critical material weaknesses in internal controls, high customer concentration, and geopolitical risks related to U.S.-China relations present substantial operational and financial risks. These factors collectively point to a highly unfavorable investment outlook.

Keywords

preventive healthcare, SEC filing, 10-Q, financial results, net loss, revenue decline, cash flow, internal controls, China operations, commission revenue, healthcare services, corporate governance, liquidity risk, U.S.-China relations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.